MYLAN 2302 MYLAN 2302 (Prazosin 2 mg)
Pill imprint MYLAN 2302 MYLAN 2302 has been identified as Prazosin hydrochloride 2 mg.
Prazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; heart failure; raynaud's syndrome; post traumatic stress disorder (and more), and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Prazosin 2 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for MYLAN 2302 MYLAN 2302 (Prazosin 2 mg)
- 2 mg
- Brown / Beige
- 18.00 mm
- Prescription only
- Drug Class:
- Antiadrenergic agents, peripherally acting
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
ferric oxide red
ferric oxide yellow
D&C Red No. 28
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Red No. 40
|NDC Code||Manufacturer / Repackager|
|51079-0631||UDL Laboratories Inc|
|54569-2583||A S Medication Solutions LLC (repackager)|
Note: Inactive ingredients may vary.
Prazosin hydrochloride is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...